Classes | Virtual Medical Academy

Viewing 1097 results

Oncology

Jaypirca: A Novel BTK Inhibitor With a Well-Tolerated Safety Profile

By :

Dr.Chaves

Oncology

How Does Jaypirca Work? The Science Explained

By :

Dr Alan Skarbnik

Diabetes

Supporting Patients with Obesity Through Comprehensive Treatment

By :

Prof.W.Timothy Garvey

Diabetes

Proposed actions of GIP and GLP1 receptor agonist in human

By :

Prof.Rachel Batterham

Diabetes

Potential Impact of Weight Reduction on Obesity-Related Complications

By :

Prof.W.Timothy Garvey

Oncology

Sparking discussions on Jaypirca – Efficacy results

By :

Dr Julio Chavez

Oncology

Sparking Discussions about Jaypirca Appropriate Patients

By :

Dr Alan Skarbnik

Oncology

Jaypirca, the first and only reversable BTK inhibitor

By :

Dr.John M Pagel

Medical Education

Writing and Assessing NCAAA Compatible Learning Outcomes

By :

Dr. Shoroog Agou

Dermatology

The efficacy of Olumiant in children and adolescents with moderate to severe atopic dermatitis.

By :

Prof. Antonio Torrelo

Dermatology

The burden of disease and unmet treatment needs in children and adolescents with moderate to severe atopic dermatitis

By :

Prof. Antonio Torrelo

Dermatology

Prescribing Olumiant for your pediatric patients: practicalities, safety profile and flexible dosing

By :

Prof. Antonio Torrelo

About Us

Support

Technical Requirements

VMA Team

Partner

Jaypirca: A Novel BTK Inhibitor With a Well-Tolerated Safety Profile

How Does Jaypirca Work? The Science Explained

Supporting Patients with Obesity Through Comprehensive Treatment

Proposed actions of GIP and GLP1 receptor agonist in human

Potential Impact of Weight Reduction on Obesity-Related Complications

Sparking discussions on Jaypirca – Efficacy results

Sparking Discussions about Jaypirca Appropriate Patients

Jaypirca, the first and only reversable BTK inhibitor

Writing and Assessing NCAAA Compatible Learning Outcomes

The efficacy of Olumiant in children and adolescents with moderate to severe atopic dermatitis.

The burden of disease and unmet treatment needs in children and adolescents with moderate to severe atopic dermatitis

Prescribing Olumiant for your pediatric patients: practicalities, safety profile and flexible dosing

Call Center 920008161

[email protected]